Evidence map›Paper›PMID 29138229›Full record

ArticleEMBO molecular medicine2018

Genomic structural variations lead to dysregulation of important coding and non-coding RNA species in dilated cardiomyopathy.

Jan Haas, Stefan Mester, Alan Lai, Karen S Frese, Farbod Sedaghat-Hamedani, Elham Kayvanpour, Tobias Rausch, Rouven Nietsch, Jes-Niels Boeckel, Avisha Carstensen and 18 more

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Clinical and genetic insights into non-compaction: a meta-analysis and systematic review on 7598 individuals.Clinical research in cardiology : official journal of the German Cardiac Society · 2019
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Differential Methylation in theInternational journal of molecular sciences · 2021
    Article
  12. The Evolving Story in the Genetic Analysis for Heart Failure.Frontiers in cardiovascular medicine · 2021
    Review
  13. Article
  14. Recent advances on the roles of LncRNAs in cardiovascular disease.Journal of cellular and molecular medicine · 2020
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 5 institutions in 2 countries.

Jan HaasDepartment of Internal Medicine III, University of Heidelberg, Heidelberg, Germany.
Stefan MesterDepartment of Internal Medicine III, University of Heidelberg, Heidelberg, Germany.
Alan LaiDepartment of Internal Medicine III, University of Heidelberg, Heidelberg, Germany.
Karen S FreseDepartment of Internal Medicine III, University of Heidelberg, Heidelberg, Germany.
Farbod Sedaghat-HamedaniDepartment of Internal Medicine III, University of Heidelberg, Heidelberg, Germany.
Elham KayvanpourDepartment of Internal Medicine III, University of Heidelberg, Heidelberg, Germany.
Tobias RauschEMBL (European Molecular Biology Laboratory), Heidelberg, Germany.
Rouven NietschDepartment of Internal Medicine III, University of Heidelberg, Heidelberg, Germany.
Jes-Niels BoeckelDepartment of Internal Medicine III, University of Heidelberg, Heidelberg, Germany.
Avisha CarstensenDepartment of Internal Medicine III, University of Heidelberg, Heidelberg, Germany.
Mirko VölkersDepartment of Internal Medicine III, University of Heidelberg, Heidelberg, Germany.
Carsten DietrichStrategy and Innovation, Siemens Healthcare GmbH, Erlangen, Germany.
Dietmar PilsSiemens AG, Corporate Technology, Vienna, Austria.
Ali AmrDepartment of Internal Medicine III, University of Heidelberg, Heidelberg, Germany.
Daniel B HolzerDepartment of Internal Medicine III, University of Heidelberg, Heidelberg, Germany.
Diana Martins BordaloDepartment of Internal Medicine III, University of Heidelberg, Heidelberg, Germany.
Daniel OehlerDepartment of Internal Medicine III, University of Heidelberg, Heidelberg, Germany.
Tanja WeisDepartment of Internal Medicine III, University of Heidelberg, Heidelberg, Germany.
Derliz MerelesDepartment of Internal Medicine III, University of Heidelberg, Heidelberg, Germany.
Sebastian BussDepartment of Internal Medicine III, University of Heidelberg, Heidelberg, Germany.
Eva RiechertDepartment of Internal Medicine III, University of Heidelberg, Heidelberg, Germany.
Emil WirszStrategy and Innovation, Siemens Healthcare GmbH, Erlangen, Germany.
Maximilian WuerstleStrategy and Innovation, Siemens Healthcare GmbH, Erlangen, Germany.
Jan O KorbelEMBL (European Molecular Biology Laboratory), Heidelberg, Germany.ORCID 0000-0002-2798-3794
Andreas KellerDepartment of Bioinformatics, University of Saarland, Saarbrücken, Germany.ORCID 0000-0002-5361-0895
Hugo A KatusDepartment of Internal Medicine III, University of Heidelberg, Heidelberg, Germany.
Andreas E PoschStrategy and Innovation, Siemens Healthcare GmbH, Erlangen, Germany benjamin.meder@med.uni-heidelberg.de andreas.posch@curetis.com.
Benjamin MederDepartment of Internal Medicine III, University of Heidelberg, Heidelberg, Germany benjamin.meder@med.uni-heidelberg.de andreas.posch@curetis.com.ORCID 0000-0003-0741-2633
Heidelberg University · DESiemens Healthineers (Germany) · DEEuropean Molecular Biology Laboratory · DESaarland University · DESiemens (Austria) · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The transcriptome needs to be tightly regulated by mechanisms that include transcription factors, enhancers, and repressors as well as non-coding RNAs. Besides this dynamic regulation, a large part of phenotypic variability of eukaryotes is expressed through changes in gene transcription caused by genetic variation. In this study, we evaluate genome-wide structural genomic variants (SVs) and their association with gene expression in the human heart. We detected 3,898 individual SVs affecting all classes of gene transcripts (e.g., mRNA, miRNA, lncRNA) and regulatory genomic regions (e.g., enhancer or TFBS). In a cohort of patients (

Indexed as

Gene Expression RegulationGenomic Structural VariationTranscriptomeAnimalsCardiomyopathy, DilatedCohort StudiesHumansMaleMiceMicroRNAsMyocardiumQuantitative Trait LociRNARNA, Long NoncodingRNA, MessengerMicroRNAsRNARNA, Long NoncodingRNA, Messengercardiac transcriptomedilated cardiomyopathyexpression quantitative trait locusgenomic structural variationheart failure

Identifiers

PMID29138229
PMCPMC5760848
OpenAlexW2768402584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.